Stoke Therapeutics, Inc.
STOK
$33.61
$0.631.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.31% | -120.80% | 1,176.88% | 60.34% | -2.86% |
| Total Depreciation and Amortization | -0.90% | -6.50% | -9.32% | -2.59% | -1.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.89% | 27.40% | -1.17% | -7.70% | -2.36% |
| Change in Net Operating Assets | 89.94% | -195.78% | 157.56% | -522.14% | -10,710.00% |
| Cash from Operations | -19.45% | -119.28% | 668.39% | -7.30% | -23.68% |
| Capital Expenditure | 14.29% | -1.32% | -261.90% | 59.22% | -123.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.22% | -1,176.05% | 1,500.93% | 102.88% | 66.11% |
| Cash from Investing | 106.12% | -1,189.18% | 1,564.47% | 102.73% | 66.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 463.18% | -59.68% | 141.90% | -93.04% | -93.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 463.18% | -59.68% | 141.90% | -93.04% | -93.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.53% | -218.06% | 773.36% | 49.83% | -391.78% |